Puma Biotechnology, Inc.
PBYI
$5.06
$0.193.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.89% | 13.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.89% | 13.97% | |||
| Cost of Revenue | -1.04% | 16.53% | |||
| Gross Profit | 5.40% | 13.21% | |||
| SG&A Expenses | -6.82% | 2.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.96% | 8.99% | |||
| Operating Income | 44.26% | 66.57% | |||
| Income Before Tax | 49.93% | 88.71% | |||
| Income Tax Expenses | 28.71% | 5.80% | |||
| Earnings from Continuing Operations | 51.05% | 96.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 51.05% | 96.87% | |||
| EBIT | 44.26% | 66.57% | |||
| EBITDA | 30.81% | 38.63% | |||
| EPS Basic | 49.15% | 96.33% | |||
| Normalized Basic EPS | 48.13% | 88.11% | |||
| EPS Diluted | 44.31% | 96.33% | |||
| Normalized Diluted EPS | 47.66% | 87.78% | |||
| Average Basic Shares Outstanding | 1.29% | 0.21% | |||
| Average Diluted Shares Outstanding | 1.57% | 0.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||